Be a Stopwatch in a Hurricane CYDY Leaders & Shareholders
IMHO, whether CYDY was "overbought" or the unscrupulous activity of Citron Research drove down the price today is not material. I believe that both were likely at play and long term the efficacy of Leronlimab will win the day.
Short & Long Term the results of the clinical trials of "CYDY's multiple shots on goal" will determine patients, shareholders and CYDY's ultimate fate.
Be a "Stopwatch in a Hurricane", was the metaphor my 10th Grade English Teacher & Soccer Coach Roger Goodwin (he was a WWII English Major) advised us to use when under stressful times.